NORTH AMERICAN BUSINESS
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
NORTH AMERICAN BUSINESS
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
NORTH AMERICAN BUSINESS
No Result
View All Result
Home ALL Industrial

DANAHER ANNOUNCES RENOWNED SCIENTISTS TO JOIN NEW SCIENTIFIC ADVISORY BOARD

by Ed Johnson
April 27, 2021
A A

DIVERSE SCIENTIFIC EXPERTISE AND PROPRIETARY INSIGHTS WILL SUPPORT COMPANY GROWTH AND IMPACT

WASHINGTON, April 26, 2021 — Danaher Corporation (NYSE: DHR) (“Danaher”), the global science and technology company, announced today the formation of a Scientific Advisory Board (“Board”) to support its innovation and investment strategy.

The Board will help the company protect and grow existing scientific innovations, support its development of new technologies and bring unique perspectives to rapidly emerging science and technology trends impacting Danaher. 

The Board is comprised of preeminent scientists, including two Nobel laureates, with global experience and research expertise across all areas of health sciences. The Board will work with Danaher’s executive leadership team and its Board of Directors to assess opportunities for M&A and to prioritize early-stage investments in strategic areas.  They will also be tasked with collaborating with Danaher’s own scientific community to create proprietary insights and develop promising innovations to support customers.

Rainer Blair, Danaher President & CEO, said: “An important part of Danaher’s competitive advantage and key to our long-term success is the innovative expertise that we bring to bear on our customers’ most pressing global health and safety needs. The scientists who have generously agreed to join our Scientific Advisory Board will play an inspirational role, working closely alongside our own teams to challenge, validate and guide our scientific agenda – aligning our priorities with our customers’ and the world’s ever-evolving needs.”

“We are at a critical inflection point in the acceleration of science and technology,” added JC Gutiérrez-Ramos, Danaher Chief Science Officer. “We are witnessing the convergence of scientific disciplines hastening opportunities to affect human health at scale, increase access to health care, reduce suffering and improve health outcomes around the world.  At Danaher, we are pleased to have such an esteemed group of minds partnering with us to envision and shape that future.”

Members of the Danaher Scientific Advisory Board are:

  • Angela Caliendo, M.D., Ph.D. Warren Alpert Foundation Professor of Medicine and Executive Vice Chair of Medicine at Alpert Medical School of Brown University; and President of Brown Physicians, Inc. Molecular Infectious diseases specialist with global reputation. 
  • James J. Collins, Ph.D. Termeer Professor of Bioengineering in the Department of Biological Engineering and Institute for Medical Engineering & Science. Leader in synthetic biology and systems biology, with a focus on applying network biology approaches to study antibiotic action, bacterial defense mechanisms, and antibiotic resistance.
  • Robert Hershberg, M.D., Ph.D. Venture Partner at Frazier Healthcare Partners.Expert in the fields of immuno-oncology and translational medicine, with a passion for the advancement of early cancer screening technologies.
  • Isaac S. Kohane, M.D., Ph.D. Marion V. Nelson Professor of Biomedical Informatics, Harvard Medical School; Chair of the Department of Biomedical Informatics, Harvard Medical School; and Associate Professor of Medicine, Brigham and Women’s Hospital. Expert in application of data – including AI – to derive new diagnoses and deliver the best care available more rapidly.
  • Amy Lynn McGuire, J.D., Ph.D. Leon Jaworski Professor of Biomedical Ethics and Director of the Center for Medical Ethics and Health Policy at Baylor College of Medicine. Expert in the clinical integration of emerging technologies, with a focus on ethical and policy issues in human genetics and genomic research.
  • David Rimm, M.D., Ph.D. Professor of Pathology and of Medicine, Director of Pathology Tissue Services, and Director of Translational Pathology, Yale School of Medicine. Specializes in Immuno-Oncology, Molecular Pathology methods including NGS and has a strong background with AI-based image analysis in Pathology.
  • Phillip A. Sharp, Ph.D. & Nobel Prize Laureate Institute Professor and Professor of Biology, MIT, and Member, Koch Institute for Integrative Cancer Research. Pioneer in the molecular biology of the mechanisms of RNA splicing and its implication for cancer.
  • Thomas C. Südhof, M.D. & Nobel Prize Laureate Avram Goldstein Professor Investigator, Howard Hughes Medical Institute; Professor, Dept. of Molecular & Cellular Physiology and of Neurosurgery, Professor (by courtesy), Dept. of Neurology & Neurological Sciences and of Psychiatry & Behavioral Science, Stanford Medicine. Pioneer in the study of how synapses work including the molecular basis for neuroscience and brain chemistry.
  • David R. Walt, Ph.D. Hansjörg Wyss Professor of Biologically Inspired Engineering, Harvard Medical School; Professor of Pathology at Brigham and Women’s Hospital; Core Faculty of the Wyss Institute at Harvard University; and Howard Hughes Medical Institute Professor. Founder of Illumina and Quanterix. Pioneered the use of microwells for the analysis of DNA, RNA and proteins, which revolutionized the field.
Tags: < Corporate Events
ShareTweetShareSend

Related Industries

Industrial

Blackstone Completes Acquisition of Majority Stake of Copeland, Formerly Emerson Climate Technologies

June 1, 2023
Industrial

Rockwell Automation Names Matt Fordenwalt Senior Vice President, Lifecycle Services

May 26, 2023
Industrial

IonicBlue® receives up to CAD $100 million investment from Canada Infrastructure Bank toward decarbonization projects

May 24, 2023
Industrial

ABB opens Robert M. Thomas Innovation Center in Memphis

May 19, 2023
Industrial

GE Announces Chief Financial Officer Transition; Names Rahul Ghai Chief Financial Officer

May 19, 2023
Industrial

Rockwell Automation and Avid Solutions Partner to Accelerate and Scale Green Hydrogen Production

May 18, 2023

Ford EV Customers To Gain Access to 12,000 Tesla Superchargers; Company to Add North American Charging Standard Port in Future EVs

May 26, 2023

...

Andrew Cornelia appointed to lead the new Mercedes-Benz charging network in North America – Christopher Trainor responsible for finance

June 1, 2023

...

GE Hitachi Announces Intent to Transfer Ownership of Vallecitos Nuclear Center

May 10, 2023

...

chevron announces agreement to acquire PDC energy

May 23, 2023

...

Baxter Announces CFO Transition

May 10, 2023

...

Alstom and EDC enter into a strategic partnership for sustainable mobility financing

May 17, 2023

...

Stellantis Invests in Lyten’s Breakthrough Lithium-Sulfur EV Battery Technology

May 26, 2023

...

BD Names Laura Boros President of Pharmaceutical Systems

June 2, 2023

...

Thermo Fisher Scientific Releases 2022 Corporate Social Responsibility Report

May 18, 2023

...

NORTH AMERICAN BUSINESS (www.na-biz.com) is a leading source of business and corporate news, information, industry trends, market updates and insights across a broad spectrum of industries in North America and worldwide.

MENU

  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

CONTACT US

EDITORIAL:     editor#na-biz.com

PARTNERSHIP:     biz#na-biz.com

HUMAN RESOURCE:     hr#na-biz.com

* (replace # with @)

  • Official Site

Copyright © NA-BIZ.COM All rights reserved.

No Result
View All Result
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

Copyright © NA-BIZ.COM All rights reserved.